The antibody is the first it developed in-house based on customer genetic information.
from CNET News https://ift.tt/36B4HaC
Thursday, January 9, 2020
23andMe licenses drug it developed to Spanish drugmaker Almirall - CNET
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment